“In the laboratory, the following medication … have been shown to decrease cannabis withdrawal and self-administration following a period of … (a model of relapse): the cannabinoid receptor agonist, nabilone , and the adrenergic agonist, lofexidine, alone and in combination with dronabinol (synthetic THC), supporting clinical testing of these medication strategies.”